RealD reports Q4 GAAP EPS (36c), consensus (34c) $RLD
Cytokinetics announces poster presentation on CK-2127107 $CYTK
Cherokee reports Q1 EPS 41c, consensus 36c $CHKE
Restoration Hardware reports Q1 adjusted EPS 23c, consensus 20c $RH
Pacific Ethanol, Aventine Renewable holders approve proposed merger $PEIX
ExOne reports Q1 EPS (53c), may not compare to consensus (29c) $XONE
Oculus reports Q4 EPS (11c), one estimate (25c) $OCLS
Korn/Ferry sees Q1 EPS 44c-50c, consensus 44c $KFY
LeapFrog reports Q4 EPS (56c), consensus (21c) $LF
Calithera Biosciences reports Phase I data for CB-839 at EHA $CALA
Aveo Pharmaceuticals announces FDA update for Tivozanib in colorectal cancer FAILS $AVEO
No comments:
Post a Comment